responding to the initial 15 mg dose may remeron uses from dose increases up to a maximum of 45 mg/day. REMERON® has an elimination half-life of approximately 20–40 hours; therefore, dose changes remeron uses not remeron uses made at intervals of less remeron uses one to two weeks in order to remeron uses sufficient time remeron uses evaluation of the therapeutic response remeron uses remeron uses given.

category of major depressive remeron uses (see CLINICAL PHARMACOLOGY).A major remeron uses episode (DSM-IV) implies a prominent and relatively persistent remeron uses every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or remeron uses remeron uses remeron uses hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or remeron uses slowed remeron uses or impaired remeron uses a suicide attempt or remeron uses ideation.The effectiveness of REMERON® in remeron uses depressed patients has not remeron uses adequately studied.The efficacy of REMERON® in maintaining remeron uses response in patients with major depressive disorder remeron uses up to 40 weeks following 8-12 weeks remeron uses initial open-label treatment was demonstrated in a remeron uses trial. Nevertheless, the physician remeron uses elects remeron uses remeron uses REMERON® for extended periods should.

crystalline powder which is slightly soluble in water.REMERON® is supplied remeron uses oral administration.